Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Opthea Ltd
OPTCurrent price
0.7 AUD
-0.045 AUD (-6.04%)
Last closed
0.76 AUD
Company
www.opthea.com
ISIN
AU000000OPT2
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
999 855 205 AUD
Yield for 12 month
+130.30 %
1Y
3Y
5Y
10Y
15Y
OPT
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia. Address: 650 Chapel Street, South Yarra, VIC, Australia, 3141
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.18 AUDP/E ratio
–Dividend Yield
–Current Year
+192 532 AUD
Last Year
+248 897 AUD
Current Quarter
+143 907 AUD
Last Quarter
+128 704 AUD
Current Year
+192 532 AUD
Last Year
-137 927 AUD
Current Quarter
+22 854 AUD
Last Quarter
-68 862 AUD
Key Figures OPT
1 year
3 years
5 years
10 years
EBITDA
-194 742 209 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-83.43 %
PEG Ratio
–
Return On Equity TTM
-3383.08 %
Wall Street Target Price
7.18 AUD
Revenue TTM
265 843 AUD
Book Value
-0.07 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-68.3 %
Dividend Yield
–
Gross Profit TTM
221 772 AUD
Earnings per share
-0.53 AUD
Diluted Eps TTM
-0.53 AUD
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OPT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OPT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
11.10.2004
Forward Annual Dividend Yield
–
Last Split Factor
1:1
Payout Ratio
–
Last Split Date
15.08.1997
Dividend Date
–
Stock Valuation OPT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
6.7476
Enterprise Value Revenue
5037.7887
Price Sales TTM
3784.5845
Enterprise Value EBITDA
-1.0623
Price Book MRQ
4.2065
Financials OPT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OPT
For 52 weeks
0.3 AUD
0.97 AUD
50 Day MA
0.78 AUD
Shares Short Prior Month
–
200 Day MA
0.61 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart